Peter LeeVice President, Chief Compliance Officer at Kura OncologySpeaker
Profile
Peter has helped build compliance programs and launch drugs at Gilead Sciences, Hyperion Therapeutics, Pharmacyclics, Heron Therapeutics and Mirati Therapeutics, and has been in the pharmaceutical industry for almost 20 years. He has his BA from University of Michigan, JD from Quinnipiac Law School and LLM from Loyola University of Chicago.
Agenda Sessions
Managing New Field-Facing Role Types – How to Mitigate Risk and Establish Guardrails
, 9:45amView Session